(Q45737373)

English

Effect of multiple mutations in the core promoter and pre-core/core region of hepatitis B virus genome on the response to interferon in e antigen-positive chronic hepatitis B.

scientific article published in April 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Effect of multiple mutations in the core promoter and pre-core/core region of hepatitis B virus genome on the response to interferon in e antigen-positive chronic hepatitis B. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Hepatitis B virus

1 reference

based on heuristic

inferred from title

author name string

Zhang X

1

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Han Y

2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Lu Z

3

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Gao J

4

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Luo Z

5

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Zhang D

6

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

publication date

1 April 2001

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Journal of Gastroenterology and Hepatology

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

393-398

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Treatment of chronic hepatitis B virus infection: an Asia-Pacific perspective

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02451.X

21 January 2018

Hepatitis B virus mutants.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02451.X

21 January 2018

Relationship between the serum alanine aminotransferase level at the end of interferon treatment and histologic changes in wild-type and precore mutant hepatitis B virus infections

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02451.X

21 January 2018

Distribution of the predominant hepatitis B virus precore variants in hepatitis B e antigen-positive children and their effect on treatment response

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02451.X

21 January 2018

Interferon-alpha 2a for chronic hepatitis B with e antigen or antibody:comparable antiviral effects on wild-type virus and precore mutant

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02451.X

21 January 2018

Genomic variations in the hepatitis B core gene: a possible factor influencing response to interferon alfa treatment.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02451.X

21 January 2018

Naturally occurring hepatitis B virus mutants with deletions in the core promoter region

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02451.X

21 January 2018

The precore/core promoter mutant (T1762A1764) of hepatitis B virus: clinical significance and an easy method for detection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02451.X

21 January 2018

Update on clinical trials in the treatment of hepatitis B.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02451.X

21 January 2018

Seroconversion from Hepatitis B e Antigen to Antibody in Chronic Type B Hepatitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02451.X

21 January 2018

Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02451.X

21 January 2018

Detection of serum hepatitis B virus DNA in patients with chronic hepatitis using the polymerase chain reaction assay

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02451.X

21 January 2018

Mutations in the core promoter/enhancer II regions of naturally occurring hepatitis B virus variants and analysis of the effects on transcription activities

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02451.X

21 January 2018

Prevalence of mutations in core promoter/precore region in Japanese patients with chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02451.X

21 January 2018

Wild-type levels of pregenomic RNA and replication but reduced pre-C RNA and e-antigen synthesis of hepatitis B virus with C(1653) --> T, A(1762) --> T and G(1764) --> A mutations in the core promoter

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02451.X

21 January 2018

Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02451.X

21 January 2018

Probable implication of mutations of the X open reading frame in the onset of fulminant hepatitis B.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02451.X

21 January 2018

T1762/A1764 variants of the basal core promoter of hepatitis B virus; serological and clinical correlations in Chinese patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02451.X

21 January 2018

Mutation of nucleotide 1,762 in the core promoter region during hepatitis B e seroconversion and its relation to liver damage in hepatitis B e antigen carriers

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02451.X

21 January 2018

Interferon treatment in patients with chronic hepatitis B: A meta-analysis of the published literature

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02451.X

21 January 2018

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02451.X

21 January 2018

Identifiers

10.1046/J.1440-1746.2001.02451.X

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45737373&oldid=1287858232"